Localization of active forms of C-jun kinase (JNK) and p38 kinase in Alzheimer's disease brains at different stages of neurofibrillary degeneration

Journal of Alzheimer's Disease

Volumn 3, Issue 1, 2001, Pages 41-48

  Pei, Jin Jing ^a   Braak, Eva ^b   Braak, Heiko ^b   Grundke Iqbal, Inge ^c   Iqbal, Khalid ^c   Winblad, Bengt ^a   Cowburn, Richard F ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b GOETHE UNIVERSITY   (Germany)

^c NEW YORK STATE INSTITUTE FOR BASIC RESEARCH IN DEVELOPMENTAL DISABILITIES   (United States)

Author keywords

Alzheimer's disease; JNK; Neurofibrillary tangles; p38 kinase

Indexed keywords

AMYLOID; PHOSPHOTRANSFERASE; PROTEIN KINASE P38; STRESS ACTIVATED PROTEIN KINASE; TAU PROTEIN; UNCLASSIFIED DRUG;

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DEPHOSPHORYLATION; ENTORHINAL CORTEX; ENZYME ACTIVATION; FEMALE; HIPPOCAMPUS; HUMAN; HUMAN TISSUE; MALE; NERVE DEGENERATION; NEUROFIBRILLARY TANGLE; PAIRED HELICAL FILAMENT; PRIORITY JOURNAL; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; TEMPORAL CORTEX;

EID: 0035087703     PISSN: 13872877     EISSN: None     Source Type: Journal    
DOI: 10.3233/JAD-2001-3107     Document Type: Article

References (38)

1. Über eigenartige krankheitsfälle des späteren alters
2. Accumulation of abnormally phosphorylated tau precedes the formation of neurofibrillary tangles in Alzheimer's disease
3. Zur kenntnis der Alzheimer'schen krankheit (präsenilen demenz mit herdsymptomen)
4. ERKs: A family of protein-serine/threonine kinases that are activated and tyrosine phosphorylated in response to insulin and NGF
5. Silver impregnation of Alzheimer's neurofibrillary changes counterstained for basophilic material and lipofuscin pigment
6. A sequence of cytoskeleton changes related to the formation of neurofibrillary tangles and neuropil threads
7. Neuropathological staging of Alzheimer-related changes
8. Alzheimer's plaques and tangles: A controlled and enhanced silver-staining method
9. Silver staining of Alzheimer's neurofibrillary changes by means of physical development
10. Activation of the novel stress-activated protein kinase SAPK4 by cytokines and cellular stresses is mediated by SKK3 (MKK6); comparison of its substrate specificity with that of other SAP kinases
11. Phosphoprotein phosphatase activities in Alzheimer's disease brain
12. Phosphatase activity toward abnormally phosphorylated τ: Decrease in Alzheimer disease brain
13. Microtubule-associated protein tau, a component of Alzheimer paired helical filaments
14. Abnormal phosphorylation of the microtubule-associated protein tau in Alzheimer cytoskeletal pathology
15. p38 kinase is activated in the Alzheimer's disease brain
16. Defective brain microtubule assembly in Alzheimer disease
17. Identification and localization of a tau peptide to paired helical filaments of Alzheimer disease
18. Ubiquination and abnormal phosphorylation of paired helical filaments in Alzheimer's disease
19. cAMP-dependent protein kinase phosphorylations on tau in Alzheimer's disease
20. Tau protein in normal and Alzheimer's disease brain: An update
21. Implication of brain cdc2 and MAP kinases in the phosphorylation of tau protein in Alzheimer's disease
22. β-amyloid fibrils activate parallel mitogen-activated protein kinase pathways in microglia and HTP1 monocytes
23. Conversion of p35 to p25 deregulates cdk5 activity and promotes neurodegeneration
24. Accumulation of cyclin-dependent kinase-5 (cdk5) in neurons with early stages of Alzheimer's disease neurofibrillary degeneration
25. Accumulation of cyclin-dependent kinase 5 (cdk5) in neurons with early stages of Alzheimer's disease neurofibrillary degeneration
26. Distribution of active glycogen synthase kinase 3β (GSK-3β) in brains staged for Alzheimer's disease neurofibrillary changes
27. The distribution of active form of mitogen activated protein (MAP) kinase in Alzheimer's neurofibrillary pathology
28. Activation of neuronal extracellular receptor kinase (ERK) in Alzheimer disease links oxidative stress to abnormal phosphorylation
29. Reactivating kinase/p38 phosphorylates τ protein in vitro
30. Stress-activated protein kinase/c-Jun N-terminal kinase phosphorylates τ protein
31. Mitogen activated protein kinase pathway
32. Phosphorylation of tau at both Thr 231 and Ser 262 is required for maximal inhibition of its binding to microtubules
33. Primary involvement of oxidative damage and redox imbalance in Alzheimer and other neurodegenerative diseases
34. Aberrant expression of mitotic cdc2/cyclin B1 kinase in degenerating neurons of Alzheimer's disease brain
35. τ is phosphorylated by GSK-3 at several sites found in Alzheimer disease and its biological activity markedly inhibited only after it is prephosphorylated by A-kinase
36. Preferential labeling of Alzheimer neurofibrillary tangles with antisera for tau protein kinase (TPKI)/glycogen synthase kinase-3β and cyclin-dependent kinase 5, a component of TPK II
37. Activation of p38 kinase links τ phosphorylation, oxidative stress and cell cycle-related events in Alzheimer disease
38. Activation of mitogen-activated kinase pathways links tau phosphorylation, oxidative stress and cell cycle-related events in Alzheimer disease